Alkem enters exclusive license agreement with Johns Hopkins University
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
The aim is to strengthen industry-academia cooperation
The new centre will comprise a team of 50 highly experienced specialists
It would be the first protein-based alternative available in Israel
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
Subscribe To Our Newsletter & Stay Updated